Decoding the Role of Water Dynamics in Ligand-Protein Unbinding: CRF1R as a Test Case

被引:45
作者
Bortolato, Andrea [1 ]
Deflorian, Francesca [1 ]
Weiss, Dahlia R. [1 ]
Mason, Jonathan S. [1 ]
机构
[1] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England
关键词
BINDING-KINETICS; MOLECULAR-DYNAMICS; RESIDENCE TIME; RECEPTOR; ANTAGONISTS; EFFICIENT; METADYNAMICS; TRANSITIONS; ASSOCIATION; COMPLEXES;
D O I
10.1021/acs.jcim.5b00440
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The residence time of a ligand protein complex is a crucial aspect in determining biological effect in vivo. Despite its importance, the prediction of ligand k(off) still remains challenging for modern computational chemistry. We have developed aMetaD, a fast and generally applicable computational protocol to predict ligand protein unbinding events using a molecular dynamics (MD) method based on adiabatic-bias MD and metadynamics. This physics-based, fully flexible, and pose-dependent ligand scoring function evaluates the maximum energy (RTscore) required to move the ligand from the bound-state energy basin to the next. Unbinding trajectories are automatically analyzed and translated into atomic solvation factor (SF) values representing the water dynamics during the unbinding event. This novel computational protocol was initially tested on two M-3 muscarinic receptor and two adenosine A(2A) receptor antagonists and then evaluated on a test set of 12 CRF1R ligands. The resulting RTscores were used successfully to classify ligands with different residence times. Additionally, the SF analysis was used to detect key differences in the degree of accessibility to water molecules during the predicted ligand unbinding events. The protocol provides actionable working hypotheses that are applicable in a drug discovery program for the rational optimization of ligand binding kinetics.
引用
收藏
页码:1857 / 1866
页数:10
相关论文
共 48 条
[1]
Role of the active-site solvent in the thermodynamics of factor Xa ligand binding [J].
Abel, Robert ;
Young, Tom ;
Farid, Ramy ;
Berne, Bruce J. ;
Friesner, Richard A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (09) :2817-2831
[2]
CRF and CRF receptors: Role in stress responsivity and other behaviors [J].
Bale, TL ;
Vale, WW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :525-557
[3]
Well-tempered metadynamics: A smoothly converging and tunable free-energy method [J].
Barducci, Alessandro ;
Bussi, Giovanni ;
Parrinello, Michele .
PHYSICAL REVIEW LETTERS, 2008, 100 (02)
[4]
The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]
Transition path sampling: Throwing ropes over rough mountain passes, in the dark [J].
Bolhuis, PG ;
Chandler, D ;
Dellago, C ;
Geissler, PL .
ANNUAL REVIEW OF PHYSICAL CHEMISTRY, 2002, 53 :291-318
[6]
Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study [J].
Bortolato, Andrea ;
Tehan, Ben G. ;
Bodnarchuk, Michael S. ;
Essex, Jonathan W. ;
Mason, Jonathan S. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (07) :1700-1713
[7]
From A to B in free energy space [J].
Branduardi, Davide ;
Gervasio, Francesco Luigi ;
Parrinello, Michele .
JOURNAL OF CHEMICAL PHYSICS, 2007, 126 (05)
[8]
Canonical sampling through velocity rescaling [J].
Bussi, Giovanni ;
Donadio, Davide ;
Parrinello, Michele .
JOURNAL OF CHEMICAL PHYSICS, 2007, 126 (01)
[9]
Investigating Drug-Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms [J].
Cavalli, Andrea ;
Spitaleri, Andrea ;
Saladino, Giorgio ;
Gervasio, Francesco L. .
ACCOUNTS OF CHEMICAL RESEARCH, 2015, 48 (02) :277-285
[10]
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design [J].
Congreve, Miles ;
Andrews, Stephen P. ;
Dore, Andrew S. ;
Hollenstein, Kaspar ;
Hurrell, Edward ;
Langmead, Christopher J. ;
Mason, Jonathan S. ;
Ng, Irene W. ;
Tehan, Benjamin ;
Zhukov, Andrei ;
Weir, Malcolm ;
Marshall, Fiona H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) :1898-1903